Taysha Gene Therapies, Inc. (TSHA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $343.32M | +114.1% |
| 2024 | $160.36M | -7.2% |
| 2023 | $172.73M | +36.8% |
| 2022 | $126.28M | -41.0% |
| 2021 | $213.96M | -17.4% |
| 2020 | $258.88M | +1725773.3% |
| 2019 | $15.0K | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $343.32M | +114.1% |
| 2024 | $160.36M | -7.2% |
| 2023 | $172.73M | +36.8% |
| 2022 | $126.28M | -41.0% |
| 2021 | $213.96M | -17.4% |
| 2020 | $258.88M | +1725773.3% |
| 2019 | $15.0K | — |